Richard Burgess
Vascular Neurology · Toledo, OHNPI 1649340530
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,519 of the $3,875 with a category attached, or 65.0%. 26 manufacturers reported payments, led by Insightec,inc at 35.0% of the total. Reporting peaked in 2019 at $1,936 and has fallen 84.9% since, to $293 in 2025.
Across 57 payments — averaging $67.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insightec,inc$1K
- Stryker$839
- Medtronic$565
- Microvention, Inc.$285
- Johnson & Johnson$125
- Chiesi USA, Inc.$120
- plus $585 from 20 others
What the payments were for
- Travel & lodging$1,35735%
- Food & beverage$2,51965%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insightec,inc | 1 | $1,357 |
| Stryker | 8 | $839 |
| Medtronic(2 entities) | 12 | $565 |
| Microvention, Inc. | 3 | $285 |
| Johnson & Johnson | 1 | $125 |
| Chiesi USA, Inc. | 1 | $120 |
| Medical Device Business Services, Inc. | 1 | $94 |
| SK Life Science, Inc. | 4 | $63 |
| TG Therapeutics, Inc. | 2 | $49 |
| Pfizer | 3 | $42 |
| EMD Serono, Inc. | 2 | $41 |
| Kyowa Kirin, Inc. | 2 | $40 |
| E.r. Squibb & Sons, L.L.C. | 3 | $39 |
| Penumbra, Inc. | 2 | $27 |
| Eisai Inc. | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| AstraZeneca | 1 | $18 |
| Argenx US, Inc. | 1 | $17 |
| Merz Pharmaceuticals, LLC | 1 | $16 |
| Biocodex, Inc. | 1 | $16 |
| Biogen | 1 | $15 |
| Acadia Pharmaceuticals Inc | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Bristol Myers Squibb | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AXS VECTA 71$414
- AXS INFINITY LS$294
- Pipeline$282
- SURPASS EVOLVE$273
- SOFIA 6F-131CM STR$143
- STENT$143
- Embotrap$125
- CLEVIPREX$120
- Sofia$106
- WEB$106
- LVIS Jr.$106
- HydroSoft 3D Coil$106
How this compares
$3,875 in reported general payments places this provider in the 60th percentile of 43 vascular neurology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 28 | $112 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in Toledo
- Osama ZaidatToledo$844K
- Syed ZaidiToledo$26K
- Eugene LinToledo$19K
- Nicholas LiawToledo$6K
- Vieh KungToledo$5K
- Aixa Espinosa-MoralesToledo$177
- Muhammad HussainCleveland$105K
- Matthew FlahertyCincinnati$71K
- Gabor TothCleveland$34K
- Brian KatzColumbus$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.